Antibody binding to human airway trypsin-like enzyme and utilization thereof

摘要

Problems of the present invention are to provide methods for diagnosing the morbid state based on the assay of a human airway trypsin-like protease in a biosample and to provide a therapeutic agent for diseases associated with the human airway trypsin-like protease. Such problems are solved with antibodies binding to the human airway trypsin-like protease and an enzyme immunoassay using the antibodies. Furthermore, the problems are solved with a therapeutic agent comprising the antibodies inhibiting the activation of the human airway trypsin-like protease and a therapeutic agent comprising the antibodies neutralizing the human airway trypsin-like protease activity.